On September 14, 2018, GHP magazine (Global Health & Pharma) announced Accell Clinical Research as one of the winners of the Healthcare & Pharmaceutical Awards 2018, ‘The Best Clinical Trial Management Firm – Eastern Europe’.

It is an honor for Accell to be highly recognized as an organization that contributes greatly to the development in the life sciences industry and specifically within clinical trial management.

GHP is a quarterly magazine published by AI Global Media Ltd. According to a GHP commentary, it ‘prides itself on the validity of its awards and winners. The awards are given solely on merit and are awarded to commend those most deserving for their ingenuity and hard work, distinguishing them from their competitors and proving them worthy of recognition’.

It is not the first time that Accell Clinical Research has been nominated and highly recognized by winning prominent awards. In 2015 Accell received a CRO Leadership Award for Reliability presented by Life Science Leader Magazine. The award was a result of a feedback survey by pharmaceutical and biotech companies in various categories of CRO services they received. Having won a new award again this year only proves positive steady dynamics of Accell’s development, growth, and excellence.

Svetlana Kazanskaya, Accell’s Director of Business Development, talked to a GHP Magazine’s reporter about the unique business principles and practices of the company that contributed greatly to its outstanding performance. You can read the full interview in the ‘GHP Q3 2018’ issue, which is also available on Accell’s website.

This year’s award is a testament of all the hard work that every team member has put in. Accell cordially thanks all its employees, partners, and clients for trust and promises to keep on fostering best practices of clinical research in Eastern Europe, Russia, and CIS countries. Accell is grateful to everyone who voted for our victory.